Viewing Study NCT00294632


Ignite Creation Date: 2025-12-24 @ 9:23 PM
Ignite Modification Date: 2025-12-27 @ 11:18 PM
Study NCT ID: NCT00294632
Status: COMPLETED
Last Update Posted: 2020-02-24
First Post: 2006-02-20
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Lenalidomide and Rituximab in the Treatment of Relapsed Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell Lymphoma
Sponsor: M.D. Anderson Cancer Center
Organization: